| First Author | Zhang Y | Year | 2013 |
| Journal | Immunology | Volume | 140 |
| Issue | 4 | Pages | 430-40 |
| PubMed ID | 23859136 | Mgi Jnum | J:209555 |
| Mgi Id | MGI:5568064 | Doi | 10.1111/imm.12152 |
| Citation | Zhang Y, et al. (2013) Loss of beta-arrestin 2 exacerbates experimental autoimmune encephalomyelitis with reduced number of Foxp3+ CD4+ regulatory T cells. Immunology 140(4):430-40 |
| abstractText | beta-Arrestins are well-known regulators and mediators of G protein-coupled receptor signalling, and accumulating evidence reveals that they are functionally involved in inflammation and autoimmune diseases. Of the two beta-arrestins, beta-arrestin 1 is documented to play regulatory roles in an animal model of multiple sclerosis (MS), whereas the role of beta-arrestin 2 is less clear. Here, we show that beta-arrestin 2-deficient mice displayed the exacerbated and sustained symptoms of experimental autoimmune encephalomyelitis (EAE), an animal model of MS. At the cellular level, deficiency of beta-arrestin 2 led to a decreased number of Foxp3(+) CD4(+) regulatory T (Treg) cells in peripheral lymphoid organs of EAE mice. Consistently, our in vitro observations also revealed that loss of beta-arrestin 2 impaired the conversion of Foxp3(-) CD4(+) T cells into Foxp3(+) CD4(+) inducible Treg cells. Taken together, our data suggest that beta-arrestin 2 plays a regulatory role in MS, that is opposite to that of beta-arrestin 1, in autoimmune diseases such as MS, which is at least partially through regulation of iTreg cell differentiation. |
